German biotech CureVac’s CEO, Franz-Werner Haas, said on Thursday that they are planning to produce 300-400 million doses of their coronavirus vaccine in 2021, as reported by Reuters.
Tags coronavirus
Check Also
Bitcoin Retreats Below $95K Amid Trade Tariff Fears and Profit-Taking
Bitcoin continued its pullback on Tuesday, retreating 3.6% to $94,567.1 by early morning trade as …